Hyderabad-based pharma major Matrix Laboratories Ltd on Wednesday said it received Rs 75 crore (Rs 750 million) as a part payment towards the settlement of a potential patent infringement suit.
The company informed the National Stock Exchange that of the estimated consideration of Rs 95 crore (Rs 950 million) towards the settlement of a potential patent infringement suit, it had received Rs 75 crore as a part payment.